FDA 510(k)

GENESEEQPRIME NGS Tumor Profiling Assay (FFPE) (GS6005)

K-Nummer: K250003 · 2025-08-29

Entscheidungsdatum2025-08-29

ProduktcodePZM

BeratungsausschussPA

EntscheidungSubstantially Equivalent

Produktübersicht

GENESEEQPRIME NGS Tumor Profiling Assay (FFPE) (GS6005) is the device name listed in this FDA 510(k) record. The listed applicant is Geneseeq Technology, Inc.. It received FDA 510(k) clearance on 2025-08-29 under 510(k) number K250003. The device is classified under product code PZM. It was reviewed by the PA advisory panel. FDA Decision: Substantially Equivalent.

Häufig gestellte Fragen

What is the GENESEEQPRIME NGS Tumor Profiling Assay (FFPE) (GS6005)?

GENESEEQPRIME NGS Tumor Profiling Assay (FFPE) (GS6005) is a medical device that received FDA 510(k) clearance on 2025-08-29. The listed applicant is Geneseeq Technology, Inc.. The 510(k) number is K250003.

When did GENESEEQPRIME NGS Tumor Profiling Assay (FFPE) (GS6005) receive FDA 510(k) clearance?

GENESEEQPRIME NGS Tumor Profiling Assay (FFPE) (GS6005) received FDA 510(k) clearance on 2025-08-29, under 510(k) number K250003.

Who is the listed applicant for GENESEEQPRIME NGS Tumor Profiling Assay (FFPE) (GS6005)?

The FDA 510(k) record lists Geneseeq Technology, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for GENESEEQPRIME NGS Tumor Profiling Assay (FFPE) (GS6005)?

The FDA product code for GENESEEQPRIME NGS Tumor Profiling Assay (FFPE) (GS6005) is PZM.

Zugehörige klinische Studien

Zugehörige Einträge werden automatisch anhand von Namen, Produktcodes oder anderen Metadaten abgeglichen. Eine Übereinstimmung begründet kein verifiziertes klinisches, wissenschaftliches, unternehmerisches oder regulatorisches Verhältnis; prüfen Sie die verlinkten offiziellen Quellen.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITING NCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITING NCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDED NCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Verwandte Geräte (Code: PZM)

K260235CellDx-TissueDatar Cancer Genetics Private Limited K241868xR IVDTempus AI, Inc.K210017ACTOnco, ACTOnco IVDAct Genomics K202304NYU Langone Genome PACT (Genome Profiling of Actionable Cancer Targets)Nyu Langone Medical Center K192063PGDx elio tissue completePersonal Genome Diagnostics K190661Omics CoreNanthealth, Inc.

Offizielle Quelle

In der FDA-Datenbank anzeigen →

Daten aus der FDA Open API. Für die aktuellsten und verbindlichen Informationen konsultieren Sie bitte stets den offiziellen Datensatz.